Health
Rapid development of functionally diverse SARS-COV-2 mouse monoclonal antibodies – News-Medical.Net
Now, a recent study published on the preprint server bioRxiv in October 2020 reports the development of a rapid process for generating high-affinity mouse mAbs,…
With the resurgence of the COVID-19 pandemic looming large in many parts of the world, the need for immunological tools such as monoclonal antibodies (mAbs) is more urgent, whether for diagnosis, treatment, or research on the virus. Now, a recent study published on the preprint server bioRxiv* in October 2020 reports the development of a rapid process for generating high-affinity mouse mAbs, and their functional attributes.
The RBD in SARS-CoV-2 Immunology
The focus of most antibody developmen…
-
Noosa News10 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business15 hours agoFord CEO makes stunning prediction about artificial intelligence
-
Business14 hours agoWhere will Nvidia stock be in 1 year?
-
Noosa News23 hours agoDarling Downs Zoo gives update on woman who lost her arm in lion attack